Skip links

Revamping Engagement Models for Business Transformation

Jump To Section

Technology is changing the world at a speed never seen before. This is dramatically changing customer behavior and their expectations from businesses, who are struggling hard to keep up to the tide.

Technology is changing the world at a speed never seen before. This is dramatically changing customer behavior and their expectations from businesses, who are struggling hard to keep up to the tide. Business transformation is what every enterprise needs today to stay relevant in the near future, which goes beyond the purview of what digital transformation alone brings to the table.

This is also changing the way business has traditionally engaged with technology, which was a lot more in silo and disparately connected. Today, technology is the key driving force in the way businesses run both internally and externally. The expectation of the business from technology, therefore, is now more connected and integrated. Hence, traditional engagement models are failing in several instances and new technology models are gaining more success in their partnerships.

The point being that business transformation requires a whole new approach and a different set of people with specific skill sets. Forward looking enterprises who are seriously looking at modernizing their business and evolving customer experience, need a special type of companies to partner with as compared to traditional consulting and outsourcing models.

Driving Business Transformation for Relevant Outcomes

What does it mean? Enterprises are looking for companies who bring ‘practitioners’ who can create end-to-end solutions, and work with both business and technology to achieve relevant business outcomes. They have the ability to create the business transformation architecture based on their horizontal domain-based knowledge.

Practitioners are people who work closely with business to identify and define the set of business outcomes, prioritize, and build an incremental roadmap, instead of a typical big bang approach that usually fails to address definitive issues. Especially when it comes to data related transformation, practitioners are able to define the relevant sources of data. Then they bring data engineering scrum teams who assimilate data from various sources and connect them back to business. They are also the data scientists who work with the business and technology teams to apply the effective algorithms, build dashboards, and provide effective and predictive analytics. Then there are the transformation product engineering teams who ultimately create the products that are derived from these insights and are built to deliver outcomes.

Another crucial part of a business transformation program is the discipline and the governance framework that centrally manages, monitors, and ensures the effectiveness of the initiative. Enterprises need to focus on an innovation framework that helps in maintaining this discipline and add more value to the whole transformation exercise.

This is applicable to every business, be it in the retail, manufacturing, healthcare, automotive or the financial services domain, where change is rapid and directly affects the consumer. It takes one disruptor to bite the largest chunk of pie from established behemoths in any domain. As Einstein has famously said, “we cannot solve our problems using the same thinking we used when we created them.” We have several examples where the failure to evolve the thought process has led to the extinction of successful, established businesses.

Today, however, I feel quite hopeful as I see many enterprises have started to change their thinking towards technology and the providers they choose as partners. It will be interesting to wait and watch the remarkable outcomes these new partnerships will bring to the market and to consumers.

You can also read this blog on Silicon Village.

Raj Vattikuti

Raj Vattikuti

Raj Vattikuti is an American-Indian entrepreneur, business executive and philanthropist. He is the Founder and Chairman of Altimetrik Corp. He is also the founder of Vattikuti Foundation. through which he is involved in many charitable causes.

Latest Reads

Subscribe

Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes